508: Investigating Genetic Profiles and Phenotypes of People with Parkinson's Disease - Dr. Paul Cannon
Dr. Paul Cannon is the Parkinson\u2019s Disease Program Manager at 23andMe. Paul and the team at 23andMe are working with patients, genetic data, and other self-report data to understand genetic mutations linked to Parkinson\u2019s disease, disease risk factors, and other comorbidities experienced by people with Parkinson\u2019s disease. Outside of work, Paul enjoys traveling to visit new places in countries or parts of countries that are not necessarily considered typical tourist destinations. He also likes to hike, watch cricket matches, and watch Premier League Soccer games. Paul received his Master\u2019s degree in Natural Sciences from Christ\u2019s College in Cambridge and his PhD in Medical Sciences from the University of Calgary. Afterwards, he worked as a Research Scientist at Syntex. Next, Paul spent nearly 15 years in various roles at Roche Pharmaceuticals and Genentech. He worked as a Senior Consultant for Tynan Consulting for about four years before joining the team at 23andMe. In our interview, Paul tells us more about his life and science.